Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2023 01:00 ET | Source: Azafaros BV

Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled

Azafaros’ Phase 2 RAINBOW study, evaluating nizubaglustat in GM2 and NPC patients, is now fully enrolled Topline data from the study, expected for mid-2024, will support two pivotal Phase...
November 07, 2023 07:00 ET | Source: Research Nester

Epigenetics Market revenue to hit USD 5 Billion by 2035, says Research Nester

New York , Nov. 07, 2023 (GLOBE NEWSWIRE) -- The global epigenetics market size is poised to grow at a CAGR of over 17% from 2023 to 2035. The market is anticipated to garner a revenue of USD 5...
October 23, 2023 23:05 ET | Source: Allied Market Research

Orphan Drugs Market Is Projected to Gain $4,35,686.3 Million By 2030, Claims Allied Market Research

Wilmington, Delaware, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Allied Market Research's report provided an estimation of the global orphan drugs market size estimated at $1,40,000.0 million in 2020 and is...
February 02, 2023 06:18 ET | Source: Vantage Market Research

Artificial Intelligence in Drug Discovery Market Size & Share to Surpass $4197.5 Million by 2028 | Vantage Market Research

WASHINGTON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- According to the report published by Vantage Market Research, the Global Artificial Intelligence (AI) in Drug Discovery Market garnered $ 627.1 Million...
November 17, 2021 14:25 ET | Source: Vantage Market Research

Global Orphan Drugs Market to Reach USD 3,199.3 Million by 2028; Increasing Prevalence of Rare Diseases among Global Population Driving the Orphan Drugs Market, States Vantage Market Research

WASHINGTON, Nov. 17, 2021 (GLOBE NEWSWIRE) -- The global orphan drugs market size is expected to reach USD 3,199 Million by 2028, exhibiting a CAGR of 7.4% during the forecast period. Increasing...
April 23, 2020 15:00 ET | Source: Reports and Data

Artificial Intelligence in Drug Discovery Market To Reach USD 2.13 Billion By 2027 | Reports and Data

New York, April 23, 2020 (GLOBE NEWSWIRE) -- According to Reports and Data, the Artificial Intelligence in Drug Discovery Market was valued at USD 253.8 million in 2019 and is expected to reach USD...
July 20, 2018 16:05 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, July 20, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
July 17, 2018 18:55 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering

SAN DIEGO, July 17, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of...
June 21, 2018 07:30 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Awarded up to $3.2 Million in SBIR Grants for Congenital Hyperinsulinism and Acromegaly

SAN DIEGO, June 21, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel...
June 18, 2018 16:05 ET | Source: Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Appoints Alan Krasner, M.D., as Chief Medical Officer

SAN DIEGO, June 18, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel...

Next Page keyboard_arrow_right